Free alerts

Broadwood Partners, L.P.: insider buys

Every open-market stock purchase reported by Broadwood Partners, L.P. to the SEC on Form 4.

Total bought$8.80M
Purchases3
Companies2
Last purchase filedNov 19, 2026
Return on these buys-18%

Broadwood Partners, L.P. has made 3 open-market purchases worth $8.80M in 2 companies since Apr 27, 2026, according to SEC Form 4 filings. The most recent was filed on Nov 19, 2026: 1,000,000 shares of LCTX at $0.77 (Director, 10% Owner), worth $770.70K. The largest was $6M of IMDX on Nov 17, 2026. Taken together, these purchases are down 18% at the latest closing prices (split-adjusted, weighted by amount).

New to insider data? Read how to read a Form 4 and which insider buys matter.

Companies Broadwood Partners, L.P. bought

TickerCompanyRoleBuysTotalSince buyLast filed
IMDXInsight Molecular Diagnostics Inc.10% Owner2$8.03M-21%Nov 19
LCTXLineage Cell Therapeutics, Inc.Director, 10% Owner1$770.70K+6.4%Nov 19

Get the next Broadwood Partners, L.P. purchase on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.

Join free on Telegram

All purchases

FiledStockInsiderValueSharesPriceSince buyStakeTrade
Nov 19LCTXLineage Cell Therapeutics, In…Broadwood Partners, L.P. +2Director, 10% Owner$770.70K1,000,000$0.77+6.4%+2%Nov 17SEC
Nov 19IMDXInsight Molecular Diagnostics…Broadwood Partners, L.P. +2private10% Owner$6M3,428,571$1.75-9.1%+27%Nov 17SEC
Apr 27IMDXInsight Molecular Diagnostics…Broadwood Partners, L.P. +210% Owner$2.03M570,184$3.56-55%+5%Apr 23SEC